E. Kantor, C. Rehm, J. Haas, A. Chan, and E. Giovannucci, Trends in Prescription Drug Use Among Adults in the United States From, pp.1818-1849, 1999.

A. Lanas, We Are Using Too Many PPIs, and We Need to Stop: A European Perspective, The American Journal of Gastroenterology, vol.10, pp.1085-1091, 2016.
DOI : 10.1002/jhm.2330

A. Pottegård, A. Broe, J. Hallas, O. De-muckadell, A. Lassen et al., Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study, Therapeutic Advances in Gastroenterology, vol.49, issue.5, pp.671-679
DOI : 10.1155/2015/175436

S. Hollingworth, E. Duncan, and J. Martin, Marked increase in proton pump inhibitors use in Australia, Pharmacoepidemiology and Drug Safety, vol.28, issue.4, pp.1019-1043, 2010.
DOI : 10.1007/978-1-4757-4286-2

E. Sheen and G. Triadafilopoulos, Adverse Effects of Long-Term Proton Pump Inhibitor Therapy, Digestive Diseases and Sciences, vol.39, issue.4, pp.931-50, 2011.
DOI : 10.1111/j.1365-2222.2008.03125.x

I. Sheikh, A. Waghray, N. Waghray, C. Dong, and M. Wolfe, Consumer use of over-thecounter proton pump inhibitors in patients with gastroesophageal reflux disease, Am J Gastroenterol. 2014, vol.109, issue.6, pp.789-94

V. Savarino, P. Dulbecco, N. De-bortoli, A. Ottonello, and E. Savarino, The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal, European Journal of Internal Medicine, vol.37, pp.201719-201743
DOI : 10.1016/j.ejim.2016.10.007

J. Thorel, C. Mccambridge, A. Piau, M. Secher, É. Magre et al., Proton pump inhibitors: Real indication or trivialized prescription? Therapie, pp.589-593, 2016.

M. Vaezi, Y. Yang, and C. Howden, Complications of Proton Pump Inhibitor Therapy, Gastroenterology, vol.153, issue.1, pp.35-48, 2017.
DOI : 10.1053/j.gastro.2017.04.047

W. Gomm, V. Holt, K. Thomé, F. Broich, K. Maier et al., Association of Proton Pump Inhibitors With Risk of Dementia, JAMA Neurology, vol.73, issue.4, pp.410-416
DOI : 10.1001/jamaneurol.2015.4791

S. Tai, C. Chien, D. Wu, K. Lin, B. Ho et al., Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan, PLOS ONE, vol.78, issue.2, p.171006, 2017.
DOI : 10.1371/journal.pone.0171006.s001

P. Arora, A. Gupta, M. Golzy, N. Patel, R. Carter et al., Proton pump inhibitors are associated with increased risk of development of chronic kidney disease, BMC Nephrology, vol.66, issue.4 Suppl 1, p.112, 2016.
DOI : 10.1271/bbb.66.192

B. Lazarus, Y. Chen, F. Wilson, Y. Sang, A. Chang et al., Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease, JAMA Internal Medicine, vol.176, issue.2, 2016.
DOI : 10.1001/jamainternmed.2015.7193

N. Shah, P. Lependu, A. Bauer-mehren, Y. Ghebremariam, S. Iyer et al., Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population. PLoS One, pp.124653-124663, 2015.

Y. Wang, Y. Chen, J. Luo, T. Chen, J. Wu et al., Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study, The American Journal of Gastroenterology, vol.8, issue.7, 2017.
DOI : 10.1111/j.1538-7836.2010.04049.x

S. Akter, M. Hassan, M. Shahriar, N. Akter, M. Abbas et al., Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software, Alzheimer's Research & Therapy, vol.52, issue.1, p.79, 2015.
DOI : 10.1016/j.neures.2005.01.008

A. Nevado-holgado, C. Kim, L. Winchester, J. Gallacher, and S. Lovestone, Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank, BMJ Open, vol.6, issue.11, p.12177, 2016.
DOI : 10.1136/bmjopen-2016-012177

C. Cassé-perrot, L. Lanteaume, J. Deguil, R. Bordet, A. Auffret et al., Neurobehavioral and Cognitive Changes Induced by Sleep Deprivation in Healthy Volunteers, CNS & Neurological Disorders - Drug Targets, vol.15, issue.7, pp.777-801, 2016.
DOI : 10.2174/1871527315666160518125156

Y. Xie, B. Bowe, T. Li, H. Xian, S. Balasubramanian et al., Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD, Journal of the American Society of Nephrology, vol.27, issue.10, pp.3153-3163, 2016.
DOI : 10.1681/ASN.2015121377

Y. Xie, B. Bowe, T. Li, H. Xian, Y. Yan et al., Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury, Kidney International, vol.91, issue.6, 2017.
DOI : 10.1016/j.kint.2016.12.021

P. Ho, T. Maddox, L. Wang, S. Fihn, R. Jesse et al., Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome, JAMA, vol.301, issue.9, pp.937-981, 2009.
DOI : 10.1001/jama.2009.261

M. Charlot, E. Grove, P. Hansen, J. Olesen, O. Ahlehoff et al., Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study, BMJ, vol.342, issue.may11 1, p.2690, 2011.
DOI : 10.1136/bmj.d2690

M. Charlot, O. Ahlehoff, M. Norgaard, C. Jørgensen, R. Sørensen et al., Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use, Annals of Internal Medicine, vol.153, issue.6, pp.378-86, 2010.
DOI : 10.7326/0003-4819-153-6-201009210-00005

O. Donoghue, M. Braunwald, E. Antman, E. Murphy, S. Bates et al., Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet, pp.989-97, 2009.

P. Lázaro, A. Cristóbal, C. Franco-peláez, J. Tarín, N. Aceña et al., Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease. PLoS One, p.169826, 2017.

D. Juurlink, T. Gomes, J. Paterson, C. Hellings, and M. Mamdani, Trends in the coprescription of proton pump inhibitors with clopidogrel: an ecological analysis, CMAJ Open, vol.3, issue.4, pp.428-459, 2015.
DOI : 10.9778/cmajo.20140078

C. Shih, Y. Chen, S. Ou, S. Li, T. Chen et al., Proton pump inhibitor use represents an independent risk factor for myocardial infarction, International Journal of Cardiology, vol.177, issue.1, pp.292-299, 2014.
DOI : 10.1016/j.ijcard.2014.09.036

G. Yepuri, R. Sukhovershin, T. Nazari-shafti, M. Petrascheck, Y. Ghebre et al., Proton Pump Inhibitors Accelerate Endothelial SenescenceNovelty and Significance, Circulation Research, vol.118, issue.12, pp.36-42, 2016.
DOI : 10.1161/CIRCRESAHA.116.308807
URL : http://circres.ahajournals.org/content/circresaha/118/12/e36.full.pdf

L. Costarelli, R. Giacconi, M. Malavolta, A. Basso, F. Piacenza et al., Different transcriptional profiling between senescent and nonsenescent human coronary artery endothelial cells (HCAECs) by Omeprazole and Lansoprazole treatment, Biogerontology. 2017, vol.18, issue.2, pp.217-236

H. Brunner, J. Cockcroft, and J. Deanfield, Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*, Journal of Hypertension, vol.23, issue.2, pp.233-279, 2005.
DOI : 10.1097/00004872-200502000-00001

J. Cooke, Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine Circulation, pp.845-53, 2013.

H. Mosli, A. Dennis, W. Kocha, L. Asher, V. Uum et al., Effect of Short-Term Proton Pump Inhibitor Treatment and Its Discontinuation on Chromogranin A in Healthy Subjects, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.9, pp.1731-1736, 2012.
DOI : 10.1210/jc.2012-1548

T. Angelone, R. Mazza, and M. Cerra, Chromogranin-A: A Multifaceted Cardiovascular Role in Health and Disease, Current Medicinal Chemistry, vol.19, issue.24, pp.4042-50, 2012.
DOI : 10.2174/092986712802430009

B. Tota, T. Angelone, and M. Cerra, The surging role of Chromogranin A in cardiovascular homeostasis. Front Chem, p.64, 2014.

M. Theurl, W. Schgoer, K. Albrecht, J. Jeschke, M. Egger et al., The Neuropeptide Catestatin Acts As a Novel Angiogenic Cytokine via a Basic Fibroblast Growth Factor-Dependent Mechanism, Circulation Research, vol.107, issue.11, pp.1326-1361, 2010.
DOI : 10.1161/CIRCRESAHA.110.219493

Y. Chen, M. Mahata, F. Rao, S. Khandrika, M. Courel et al., Chromogranin A Regulates Renal Function by Triggering Weibel-Palade Body Exocytosis, Journal of the American Society of Nephrology, vol.20, issue.7, pp.1623-1655, 2009.
DOI : 10.1681/ASN.2008111148

D. Kohan, Endothelin, hypertension and chronic kidney disease: new insights, Current Opinion in Nephrology and Hypertension, vol.19, issue.2, pp.134-143, 2010.
DOI : 10.1097/MNH.0b013e328335f91f
URL : http://europepmc.org/articles/pmc2912219?pdf=render

N. Dhaun, D. Webb, and D. Kluth, Endothelin-1 and the kidney - beyond BP, British Journal of Pharmacology, vol.127, issue.4, pp.720-751, 2012.
DOI : 10.1038/sj.bjp.0702593

F. Arif, Nephrotoxic potential of proton pump inhibitors, European Journal of Internal Medicine, vol.42, pp.953-6205, 2017.
DOI : 10.1016/j.ejim.2017.03.021

F. Cheng, Y. Ho, L. Hung, C. Chen, and T. Tsai, Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography, Journal of Chromatography A, vol.949, issue.1-2, pp.35-42, 2002.
DOI : 10.1016/S0021-9673(01)01225-0

N. Badiola, V. Alcalde, A. Pujol, L. Münter, G. Multhaup et al., The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production, PLoS ONE, vol.29, issue.3, p.58837, 2013.
DOI : 10.1371/journal.pone.0058837.g004

M. Fallahzadeh, B. Haghighi, A. Namazi, and M. , Proton pump inhibitors: predisposers to Alzheimer disease?, Journal of Clinical Pharmacy and Therapeutics, vol.7, issue.2, pp.125-131, 2010.
DOI : 10.1016/0950-3528(93)90030-V
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2710.2009.01100.x/pdf

T. Dharmarajan and E. Norkus, Does long-term PPI use result in vitamin B12 deficiency in elderly individuals? Nat Clin Pract Gastroenterol Hepatol, pp.604-609, 2008.

J. Lam, J. Schneider, W. Zhao, and D. Corley, Deficiency, JAMA, vol.310, issue.22, pp.2435-2477, 2013.
DOI : 10.1001/jama.2013.280490

R. Eastley, G. Wilcock, and R. Bucks, Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function, International Journal of Geriatric Psychiatry, vol.39, issue.3, pp.226-259, 2000.
DOI : 10.1111/j.1532-5415.1996.tb01407.x

G. Kim, H. Kim, K. Kim, J. Son, S. Kim et al., Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey, J Alzheimers Dis, vol.33, issue.3, pp.853-62, 2013.

M. Daulatzai, Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease, Journal of Neuroscience Research, vol.580, issue.204, pp.943-972, 2017.
DOI : 10.1016/j.neulet.2014.07.043
URL : http://onlinelibrary.wiley.com/doi/10.1002/jnr.23777/pdf

W. Marlicz, A. Koulaouzidis, I. Loniewski, and G. Koulaouzidis, Letter by Marlicz et al Regarding Article, ???Proton Pump Inhibitors Accelerate Endothelial Senescence???, Circulation Research, vol.119, issue.2, pp.31-33, 2016.
DOI : 10.1161/CIRCRESAHA.116.309157
URL : http://circres.ahajournals.org/content/circresaha/119/2/e31.full.pdf

C. Wiedermann, S. Kiechl, S. Dunzendorfer, P. Schratzberger, G. Egger et al., Association of endotoxemia with carotid atherosclerosis and cardiovascular disease, Journal of the American College of Cardiology, vol.34, issue.7, pp.1975-81, 1999.
DOI : 10.1016/S0735-1097(99)00448-9

A. Vaiserman, A. Koliada, and F. Marotta, Gut microbiota: A player in aging and a target for anti-aging intervention, Ageing Research Reviews, vol.35, pp.36-45
DOI : 10.1016/j.arr.2017.01.001

B. Caracciolo, W. Xu, S. Collins, and L. Fratiglioni, Cognitive decline, dietary factors and gutbrain interactions, Mech Ageing Dev, pp.59-69, 2014.

I. Martin, P. Cau, and P. Roll, HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study, PLoS One, vol.7, issue.12, p.53035, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01646470